Moser
Search Bar & Filters
Found 1 Actively Recruiting clinical trials
C
RECRUITING
Clinical study of ivonescimab for first-line treatment of metastatic NSCLC patients with high PD-L1. Evaluating overall survival and progression free survival.
18+ yearsAll GendersPHASE3
202 locations